MedMountain Ventures is a physician-founded and physician-led venture capital firm dedicated to investing in early-stage healthcare innovation that improves patient outcomes. The firm combines clinical expertise with operational excellence to support transformative healthcare technologies, including medical devices, diagnostics, digital health, and AI in healthcare.
70% of their portfolio is in Healthcare. Their most common stage is seed (50% of deals). Average disclosed round size is $6.4M (across 9 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Confido Health | Series A | $10M | Sep 2025 |
| Confido Health | Seed | $3M | Dec 2024 |
 AvoMD | Seed | $5M | Jun 2023 |
 AvoMD | Seed | $5M | Jun 2023 |
 OptionsMD | Pre-Seed | $3.8M | Nov 2022 |
 Eddii | Unknown | $2.5M | — |
| AvoMD | Series A | $3M | — |
 Inherent Biosciences | Seed | — | — |
| AAvoMD, Inc. | Seed | $5M | — |
 Epitel | Series A | $20M | — |
Top Co-Investors
Mirae Asset4 shared
Dunamu4 shared
StartUp Health4 shared
AlleyCorp4 shared
Las Olas Venture Capital4 shared
DeVC2 shared
Together Fund2 shared
ICU Ventures1 shared
Schematic Ventures1 shared
Blume Ventures1 shared
500 Global1 shared
New Enterprise Associates1 shared
Alumni Ventures1 shared
Kapor Capital1 shared
Techstars1 shared
Bread & Butter Ventures1 shared
M131 shared
FuturePlay1 shared
Noro-Moseley Partners1 shared
Springcamp1 shared
Last updated: 7 October 2026